Literature DB >> 11285366

Insights into a plasma membrane signature.

S Harvey1, Y Zhang, F Landry, C Miller, J W Smith.   

Abstract

The plasma membrane (PM) is an organized biological system that serves as a structural barrier and communication interface with the extracellular environment. Many basic questions regarding the PM as a system remain unanswered. In particular, we do not understand the scope of similarity and differences in protein expression at the PM. This study takes an initial step toward addressing these questions by comparing the PM proteomes of fibroblasts and mammary carcinoma cells. Three sets of proteins were revealed by the study. The first set comprises between 9 and 23% of all proteins at the PM and appears to be common to both fibroblasts and mammary carcinoma. A second group of proteins, comprising approximately 40% of the proteins at the PM, is tightly linked to cell lineage. The third set of proteins is unique to each cell line and is independent of cell lineage. It is reasonable to hypothesize then, that this third group of proteins is responsible for unique aspects of cell behavior. In an effort to find proteins linked to the metastatic phenotype, we identified several proteins that are uniquely expressed at the PM of the metastatic MDA-MB-435 cells. These proteins have functions ranging from cell adhesion to the regulation of translation and the control of oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285366     DOI: 10.1152/physiolgenomics.2001.5.3.129

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  12 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Signals involved in the effects of bisphenol A (BPA) on proliferation and motility of Leydig cells: a comparative proteomic analysis.

Authors:  Zhuo-Jia Chen; Kun-Shui Zhang; Li-Chen Ge; Hao Liu; Li-Kun Chen; Jun Du; Hong-Sheng Wang
Journal:  Toxicol Res (Camb)       Date:  2016-09-13       Impact factor: 3.524

Review 3.  Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Authors:  Rikke Leth-Larsen; Rikke R Lund; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2010-04-08       Impact factor: 5.911

4.  Identification of proteins differentially expressed in gastric cancer cells with high metastatic potential for invasion to lymph nodes.

Authors:  Do Hee Lee; Youra Lee; Joohyun Ryu; Sung Goo Park; Sayeon Cho; Je-Jung Lee; Chan Choi; Byoung Chul Park
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

5.  A placental sub-proteome: the apical plasma membrane of the syncytiotrophoblast.

Authors:  D D Vandré; W E Ackerman; A Tewari; D A Kniss; J M Robinson
Journal:  Placenta       Date:  2012-01-04       Impact factor: 3.481

Review 6.  Proteomics in studies of signal transduction in epithelial cells.

Authors:  Serhiy Souchelnytskyi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

7.  Enrichment of plasma membrane proteins using nanoparticle pellicles: comparison between silica and higher density nanoparticles.

Authors:  Waeowalee Choksawangkarn; Sung-Kyoung Kim; Joe R Cannon; Nathan J Edwards; Sang Bok Lee; Catherine Fenselau
Journal:  J Proteome Res       Date:  2013-01-31       Impact factor: 4.466

Review 8.  Galectin-1: a bifunctional regulator of cellular proliferation.

Authors:  Ken Scott; Cristina Weinberg
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 9.  The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1.

Authors:  Jonathan M Cousin; Mary J Cloninger
Journal:  Int J Mol Sci       Date:  2016-09-16       Impact factor: 5.923

10.  The eukaryotic translation initiation factor 3f (eIF3f) interacts physically with the alpha 1B-adrenergic receptor and stimulates adrenoceptor activity.

Authors:  Mario Javier Gutiérrez-Fernández; Ana Edith Higareda-Mendoza; César Adrián Gómez-Correa; Marco Aurelio Pardo-Galván
Journal:  BMC Biochem       Date:  2015-10-23       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.